boley nutraceuticals ltd.
boley nutraceuticals ltd. Company Information
Company Number
10179280
Website
-Registered Address
flat 41 esher park gardens, flat 41, esher, surrey, KT10 9FP
Industry
Manufacture of basic pharmaceutical products
Telephone
02031266795
Next Accounts Due
February 2025
Group Structure
View All
Directors
Anita Eyles8 Years
Shareholders
anita eyles 100%
boley nutraceuticals ltd. Estimated Valuation
Pomanda estimates the enterprise value of BOLEY NUTRACEUTICALS LTD. at £232.4k based on a Turnover of £181.1k and 1.28x industry multiple (adjusted for size and gross margin).
boley nutraceuticals ltd. Estimated Valuation
Pomanda estimates the enterprise value of BOLEY NUTRACEUTICALS LTD. at £374k based on an EBITDA of £65.2k and a 5.74x industry multiple (adjusted for size and gross margin).
boley nutraceuticals ltd. Estimated Valuation
Pomanda estimates the enterprise value of BOLEY NUTRACEUTICALS LTD. at £26k based on Net Assets of £46.7k and 0.56x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Boley Nutraceuticals Ltd. Overview
Boley Nutraceuticals Ltd. is a live company located in esher, KT10 9FP with a Companies House number of 10179280. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in May 2016, it's largest shareholder is anita eyles with a 100% stake. Boley Nutraceuticals Ltd. is a young, micro sized company, Pomanda has estimated its turnover at £181.1k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Boley Nutraceuticals Ltd. Health Check
Pomanda's financial health check has awarded Boley Nutraceuticals Ltd. a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
5 Weak
Size
annual sales of £181.1k, make it smaller than the average company (£32.2m)
- Boley Nutraceuticals Ltd.
£32.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (4.9%)
- Boley Nutraceuticals Ltd.
4.9% - Industry AVG
Production
with a gross margin of 40.4%, this company has a comparable cost of product (40.4%)
- Boley Nutraceuticals Ltd.
40.4% - Industry AVG
Profitability
an operating margin of 34.7% make it more profitable than the average company (6.9%)
- Boley Nutraceuticals Ltd.
6.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (147)
1 - Boley Nutraceuticals Ltd.
147 - Industry AVG
Pay Structure
on an average salary of £56.2k, the company has an equivalent pay structure (£56.2k)
- Boley Nutraceuticals Ltd.
£56.2k - Industry AVG
Efficiency
resulting in sales per employee of £181.1k, this is less efficient (£251.7k)
- Boley Nutraceuticals Ltd.
£251.7k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Boley Nutraceuticals Ltd.
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Boley Nutraceuticals Ltd.
- - Industry AVG
Stock Days
it holds stock equivalent to 91 days, this is in line with average (95 days)
- Boley Nutraceuticals Ltd.
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 87 weeks, this is more cash available to meet short term requirements (12 weeks)
87 weeks - Boley Nutraceuticals Ltd.
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 53.7%, this is a higher level of debt than the average (44.6%)
53.7% - Boley Nutraceuticals Ltd.
44.6% - Industry AVG
BOLEY NUTRACEUTICALS LTD. financials
Boley Nutraceuticals Ltd.'s latest turnover from May 2023 is estimated at £181.1 thousand and the company has net assets of £46.7 thousand. According to their latest financial statements, Boley Nutraceuticals Ltd. has 1 employee and maintains cash reserves of £60.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,035 | 441 | 881 | 0 | 291 | 1,664 | 2,280 |
| Intangible Assets | 4,421 | 5,894 | 840 | 1,007 | 1,175 | 1,343 | 1,511 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 5,456 | 6,335 | 1,721 | 1,007 | 1,466 | 3,007 | 3,791 |
| Stock & work in progress | 27,097 | 28,559 | 2,045 | 30,465 | 16,660 | 7,651 | 4,066 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 7,730 | 0 | 0 | 8,404 | 2,218 | 3,214 | 870 |
| Cash | 60,575 | 26,345 | 43,270 | 17,409 | 8,615 | 46,230 | 1,118 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 95,402 | 54,904 | 45,315 | 56,278 | 27,493 | 57,095 | 6,054 |
| total assets | 100,858 | 61,239 | 47,036 | 57,285 | 28,959 | 60,102 | 9,845 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 6,996 | 6,829 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 1,193 | 23,606 | 1,137 | 2,109 | 1,201 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 46,224 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 29,012 | 8,283 | 2,302 | 1,200 | 1,200 | 101,798 | 1,200 |
| total current liabilities | 36,008 | 15,112 | 3,495 | 24,806 | 2,337 | 103,907 | 48,625 |
| loans | 18,187 | 45,093 | 35,000 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 11,570 | 87,907 | 108,530 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 18,187 | 45,093 | 46,570 | 87,907 | 108,530 | 0 | 0 |
| total liabilities | 54,195 | 60,205 | 50,065 | 112,713 | 110,867 | 103,907 | 48,625 |
| net assets | 46,663 | 1,034 | -3,029 | -55,428 | -81,908 | -43,805 | -38,780 |
| total shareholders funds | 46,663 | 1,034 | -3,029 | -55,428 | -81,908 | -43,805 | -38,780 |
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | 786 | 440 | 434 | 291 | 1,373 | 1,315 | 1,140 |
| Amortisation | 1,473 | 1,474 | 167 | 168 | 168 | 168 | 168 |
| Tax | |||||||
| Stock | -1,462 | 26,514 | -28,420 | 13,805 | 9,009 | 3,585 | 4,066 |
| Debtors | 7,730 | 0 | -8,404 | 6,186 | -996 | 2,344 | 870 |
| Creditors | 0 | -1,193 | -22,413 | 22,469 | -972 | 908 | 1,201 |
| Accruals and Deferred Income | 20,729 | 5,981 | 1,102 | 0 | -100,598 | 100,598 | 1,200 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | 167 | 6,829 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | -46,224 | 46,224 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -26,906 | 10,093 | 35,000 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | -11,570 | -76,337 | -20,623 | 108,530 | 0 | 0 |
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | 34,230 | -16,925 | 25,861 | 8,794 | -37,615 | 45,112 | 1,118 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 34,230 | -16,925 | 25,861 | 8,794 | -37,615 | 45,112 | 1,118 |
boley nutraceuticals ltd. Credit Report and Business Information
Boley Nutraceuticals Ltd. Competitor Analysis
Perform a competitor analysis for boley nutraceuticals ltd. by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in KT10 area or any other competitors across 12 key performance metrics.
boley nutraceuticals ltd. Ownership
BOLEY NUTRACEUTICALS LTD. group structure
Boley Nutraceuticals Ltd. has no subsidiary companies.
Ultimate parent company
BOLEY NUTRACEUTICALS LTD.
10179280
boley nutraceuticals ltd. directors
Boley Nutraceuticals Ltd. currently has 1 director, Ms Anita Eyles serving since May 2016.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Anita Eyles | England | 63 years | May 2016 | - | Director |
P&L
May 2023turnover
181.1k
-4%
operating profit
62.9k
0%
gross margin
40.5%
+2.49%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
46.7k
+44.13%
total assets
100.9k
+0.65%
cash
60.6k
+1.3%
net assets
Total assets minus all liabilities
Similar Companies
boley nutraceuticals ltd. company details
company number
10179280
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
May 2016
age
8
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
May 2023
address
flat 41 esher park gardens, flat 41, esher, surrey, KT10 9FP
accountant
WILLIAMS & CO EPSOM LLP
auditor
-
boley nutraceuticals ltd. Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to boley nutraceuticals ltd..
boley nutraceuticals ltd. Companies House Filings - See Documents
| date | description | view/download |
|---|
